Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FNAHN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count), valued at $13,846.97 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a disease-modifying therapy used primarily in the treatment of transthyretin amyloidosis, a rare progressive disease affecting the heart and nervous system, reflecting the Defense Logistics Agency's role in supporting military and veteran healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999.999 billion and extending through December 2026. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen leverages this prime vendor arrangement to fulfill critical medical procurement requirements across multiple therapeutic domains while DLA Troop Support concurrently plans to establish Generation V Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FNAHN?
SPE2DB25FNAHN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FNAHN worth?
The government has obligated $13,847 on SPE2DB25FNAHN.
Is contract SPE2DB25FNAHN an order under another contract?
Yes. SPE2DB25FNAHN is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAHN competed?
The extent of competition for SPE2DB25FNAHN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award